A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

NYU Langone Health

Overview

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

Study Type

OBSERVATIONAL

Conditions

Finger Injuries Amputation, Traumatic

Interventions

BacitracinOTHER

For the first 30 people, bacitracin will be applied and covered with xeroform and gauze.

Skin GraftOTHER

For the next 30 patients, the amputated composite skin and soft tissue unit will be thinned out to become a full thickness skin graft.

Eligibility

Sex: ALLMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All individuals presenting at Bellevue Hospital for evaluation and treatment of a finger amputation distal to the germinal matrix that present along with the amputated distal fingertip unit. Exclusion Criteria: * replantation candidate, incomplete distal finger-tip amputation

Locations (1)

New York University School of Medicine

New York, New York, United States

Outcomes

Primary Outcomes

Time to complete healing up to 3 Months

Time frame: 3 months

Percentage of graft viability (for biological dressing only)

Time frame: 1 week

Percentage of graft viability (for biological dressing only)

Time frame: 3 weeks

Percentage of graft viability (for biological dressing only)

Time frame: 6 weeks

Percentage of graft viability (for biological dressing only)

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.